top of page

Thrombolex Receives FDA Clearance for Bashir Endovascular Catheters

Updated: May 20, 2019

May 13, 2019—Thrombolex, Inc. announced FDA 510(k) clearance for the Bashir endovascular catheter (BEC) and the Bashir N-X endovascular catheter (BEC N-X). The BEC and BEC N-X are currently only available in the United States. Plans for distribution outside the United States are forthcoming. To read more click the link below.

bottom of page